Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Kala

Sanofi reception

Sanofi indicted in France over epilepsy drug birth defects

Faces allegations over a failure to warn women about risks associated with drug

- PMLiVE

HIV vaccine based on Sanofi/GSK components fails trial

Data suggested vaccine was no more effective than placebo

Sanofi reception

Sanofi’s rare disease drug olipudase alfa scores in late-stage study

Met crucial endpoints across two clinical studies

- PMLiVE

Sanofi completes acquisition of immuno-oncology specialist Synthorx

Synthorx is now fully owned by the French drugmaker

- PMLiVE

Lucid Group Announce Neil Flash as its New Chief Commercial Officer

With over 20 years’ healthcare communications experience, Neil Flash joins Lucid Group as its Chief Commercial Officer to help lead the organisation through another exciting period of growth.

Lucid Group Communications Limited

- PMLiVE

Lucid Group adds more magic to the mix with four new hires

Leading Edge, a Lucid Group company, injects new talent into its client services and medical writing teams. Miranda Harrison joins the team as its Client Operations Director. Miranda is a...

Lucid Group Communications Limited

- PMLiVE

Lucid Group expands its presence in the north-west with six new hires

Healthcare 21, a Lucid Group company, continues to strengthen its editorial and medical writing team with six new additions to its Macclesfield office.Rosanna Farrell joins HealthCare 21 as a Senior...

Lucid Group Communications Limited

- PMLiVE

Lilly extends range of cut-price insulins in the US

Announces discounts in response to increasing pricing criticism

- PMLiVE

Lucid Group bolsters its client services and medical writing team in APAC

HealthCare21, a Lucid Group company, has appointed two new team members in its Singapore office — Siew Wyn and Megan Giliam.Wyn joins the team as a Senior Account Manager and...

Lucid Group Communications Limited

- PMLiVE

GSK, Pfizer and Sanofi among drugmakers planning price hikes in US

Pricing pressures increase amid intense political scrutiny

Sanofi reception

Sanofi narrows focus, shedding diabetes and cardiovascular research

New CEO Paul Hudson reveals strategy update

- PMLiVE

Sanofi’s sutimlimab set for filing in rare autoimmune anaemia next year

Late-stage candidate hit the mark in phase 3 study

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links